Final phase of MDMA-assisted psychotherapy trials to kick off in Vancouver | TheSpec.com

von pgd | Jan 30, 2018 | Forschung

Vancouver is one of 16 locations in the United States, Canada and Israel where clinicians hope to demonstrate that a drug historically associated with gurus and raves can revolutionize psychotherapy and trauma treatment. The B.C. Centre on Substance Use will conduct...

Psychedelic mushrooms reduce authoritarianism and boost nature relatedness, experimental study suggests

von pgd | Jan 25, 2018 | Forschung

Psilocybin, the active compound in magic mushrooms, could make people feel more connected to nature and less likely to endorse authoritarian views, according to new research from the Psychedelic Research Group at Imperial College London.The new study, published in the...

Frontiers | Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression | Pharmacology

von pgd | Jan 17, 2018 | Forschung

It is a basic principle of the “psychedelic” treatment model that the quality of the acute experience mediates long-term improvements in mental health. In line with previous reports, we hypothesized that the occurrence and magnitude of Oceanic Boundlessness (OBN)...

Magic Mushrooms Do The Opposite of Anti-Depressants, But That May Be Why They Work

von pgd | Jan 16, 2018 | Forschung

Psychedelic therapy is going through something of a revival right now, and we may now know how one such hallucinogenic drug is seemingly able to alleviate symptoms of depression. Psilocybin, the active compound in magic mushrooms, has long been known to deliver...

Psychotherapie: Drogentrips mit Heilwirkung – Spektrum.de

von pgd | Nov 24, 2017 | Aktuelles

Forscher testen LSD, Psilocybin und MDMA im Einsatz gegen psychische Erkrankungen Lange galten Drogen wie LSD, Psilocybin und MDMA als verpönt. Nun schöpfen Forscher zunehmend Hoffnung, dass sie gegen Ängste, Depressionen und Traumata helfen könnten. Quelle:...